Joey CohenMedication Adherence
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Daniel SontupeMarket Access
Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Bud BilanichSuccess Coach
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
Matt TurnerPatient Affordability
RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...
Kisqali is now the only CDK4/6 inhibitor indicated in combination with an aromatase inhibitor ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email